Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04092192 · ClinicalTrials.gov registry record · NA

Forceps vs. Snare IVC Filter Removal

A NA study of DVT, sponsored by University of Chicago.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT04092192: Recruiting NA study of DVT, sponsored by University of Chicago.

NCT04092192 is a NA study of DVT that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04092192, a NA study of DVT, is actively recruiting participants, sponsored by University of Chicago.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

IVC filters are mechanical filters placed in a patient's body to trap blood clots in the legs migrating to the lungs. When no longer indicated, interventional radiologists are consulted for IVC filter removal. Currently, many methods for extracting IVC filters exist. Two of the most common methods involve using an endovascular snare device or rigid forceps. We intend to prospectively compare these two methods in an attempt to see if one offers an advantage to the other. This will be compared by evaluating success rates and procedure time.

Primary Outcome

Data will be analyzed by a biostatistician to determine statistical differences between cohorts with respect to outcome measures.

Conditions Studied

Interventions

  • DEVICE IVC filter removal

Study Locations (1)

Illinois

  • UChicago Medicine - Chicago

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2018-12-26
Est. Completion 2028-01-30
Phase NA
University of Chicago

796 total trials

What NCT04092192 shows while recruiting

NCT04092192 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 1 condition, with DVT appearing as the primary indexed condition, and to 1 intervention - of which IVC filter removal is the first listed.

NCT04092192 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT04092192 about?

NCT04092192 is a clinical study titled "Forceps vs. Snare IVC Filter Removal". IVC filters are mechanical filters placed in a patient's body to trap blood clots in the legs migrating to the lungs. When no longer indicated, interventional radiologists are consulted for IVC filter removal. Currently, many methods for extracting IVC filters exist. Two of the most common methods i...

What is the current status of trial NCT04092192?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2018-12-26. Estimated completion is 2028-01-30.

What conditions does trial NCT04092192 study?

This clinical trial studies the following conditions: DVT.

What interventions are being tested in trial NCT04092192?

The interventions under investigation include: IVC filter removal (DEVICE).

Who is sponsoring clinical trial NCT04092192?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04092192 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for DVT

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04092192's enrollment target sits among peer trials

100 841st of 2000 higher than 1,081 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04092192, the US trial registry maintained by the National Library of Medicine. NCT04092192 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.